| __timestamp | Catalyst Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 11768000 |
| Thursday, January 1, 2015 | 11801342 | 15152000 |
| Friday, January 1, 2016 | 11369941 | 19828000 |
| Sunday, January 1, 2017 | 11375237 | 25573000 |
| Monday, January 1, 2018 | 19919204 | 23634000 |
| Tuesday, January 1, 2019 | 18842752 | 38845000 |
| Wednesday, January 1, 2020 | 16496715 | 50523000 |
| Friday, January 1, 2021 | 16936000 | 75463000 |
| Saturday, January 1, 2022 | 19789000 | 105767000 |
| Sunday, January 1, 2023 | 93150000 | 167512000 |
Unleashing the power of data
In the ever-evolving world of biopharmaceuticals, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Xenon Pharmaceuticals Inc. and Catalyst Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Xenon Pharmaceuticals Inc. has consistently increased its R&D spending, culminating in a remarkable 1,325% growth by 2023. This surge underscores Xenon's dedication to pioneering new treatments and therapies. In contrast, Catalyst Pharmaceuticals, Inc. maintained a more conservative approach, with a notable spike in 2023, where their R&D expenses surged by over 800% compared to 2014.
These trends highlight the dynamic strategies within the biopharmaceutical sector, where companies balance innovation with financial prudence to drive future growth and success.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: argenx SE vs Xenon Pharmaceuticals Inc.
Research and Development Investment: Incyte Corporation vs Xenon Pharmaceuticals Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Ascendis Pharma A/S and Xenon Pharmaceuticals Inc. Allocate Funds
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and ImmunityBio, Inc.
Research and Development: Comparing Key Metrics for Catalyst Pharmaceuticals, Inc. and Evotec SE